ArticleThe journal of liquid biopsy2024

Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer.

Naing Lin Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.